Spectrum: Autism Research News

The link reported in prior studies likely reflects confounding factors, which sibling-matched controls in the new work address.

The U.S. National Institutes of Health wants to regulate research involving cephalopods. But there aren’t enough rigorous studies to base the regulations on, veteran cephalopod researchers say.

The journal’s publisher flagged problems in 11 papers that were part of a special issue on assistive technology in special education.

This month’s Going on Trial newsletter explores a new tool for communicating with clinical trial participants and their families, among other drug development news.

This month’s Going on Trial newsletter explores how eye tracking might be used beyond helping with diagnosis, among other drug development news.

This month’s Going on Trial newsletter dives into an electroencephalography biomarker that could track the efficacy of treatments for dup15q and Angelman syndromes, among other drug development news.

Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.

Most children with the condition, however, gain communication and social abilities over time.

A dozen papers have been retracted so far, and six more are planned.

But the field needs to move on from cross-sectional studies to gain insights into the causes and consequences of the association, experts say.